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Integrins are cell surface adhesion receptors that are essen-
tial for the development and function of multicellular
 
animals. Here we summarize recent findings on the regu-
lation of integrin affinity for ligand (activation), one
 
mechanism by which cells modulate integrin function. The
focus is on the structural basis of integrin activation, the role
of the cytoplasmic domain in integrin affinity regulation, and
potential mechanisms by which activation signals are
propagated from integrin cytoplasmic domains to the extra-
cellular ligand-binding domain.
Introduction
 
Integrin adhesion receptors mediate the attachment of cells
to each other and to their surrounding extracellular matrix
 
and participate in diverse events such as hemostasis, immunity,
inflammation, and in pathological processes such as athero-
sclerosis (Schwartz et al., 1995). Integrins are noncovalent
heterodimers of type I transmembrane protein subunits
 
termed 
 

 
 and 
 

 
. Each subunit has a large (
 

 
700 residue)
 
NH
 
2
 
-terminal extracellular domain. A single membrane-
 
spanning domain links this extracellular domain to a generally
short (13–70 residue) cytoplasmic domain. Integrin-mediated
adhesion is rapidly and precisely regulated, a process that is
often a central aspect of integrin function and depends on the
integrin cytoplasmic domain interactions intracellular proteins
(Liu et al., 2000). Cells can regulate integrin-mediated adhesion
 
by changing integrin affinity for ligand (activation) (Schwartz
 
et al., 1995). Rapid changes in affinity have been widely
documented among integrins; however, affinity-independent
 
mechanisms, including changes in cell shape, cooperative
interactions promoted by integrin clustering, and changes in
the diffusion of integrins in the plane of the membrane, are
also important. The focus of this review is integrin affinity
regulation (activation) and the structural mechanisms by
which these changes in affinity occur.
 
The inside story of activation
 
Cytoplasmic interactions between integrin 
 

 
 and 
 

 
 subunits
may regulate the affinity of the integrin extracellular domain
by an allosteric mechanism (Williams et al., 1994; Hughes et
al., 1996). This mechanism implies transmission of long range
conformational rearrangements through the membrane-
spanning region (Du et al., 1993). Mutagenesis of the
membrane proximal regions of integrin cytoplasmic domains
 
(which are highly conserved within 
 

 
 and 
 

 
 subunits) suggested
that integrins are maintained in a default low affinity state, in
part, by charge interactions between the 
 

 
 and 
 

 
 subunits (for
 
integrin 
 

 
IIb
 

 
3, 
 

 
IIb Arg
 
995
 
, and 
 

 
3 Asp
 
723
 
 [Hughes et al.,
1996]). Indeed, the interaction between integrin 
 

 
 and 
 

 
 tails
can regulate activation (Lu et al., 2001). In nuclear magnetic
resonance spectroscopy (NMR)* analysis, when tethered to a
 
lipid vesicle the integrin 
 

 
IIb cytoplasmic domain adopts a
closed conformation with its COOH-terminal acidic region
proximal to the juxtamembrane region (Vinogradova et al.,
 
2000) while it is unfolded in solution. In the predicted
 
structure, 
 

 
IIb Arg
 
995
 
 is surface exposed and thus could interact
with the 
 

 
3 Asp
 
723
 
 to mediate a proposed salt bridge (Hughes
et al., 1996). Certain mutations, which activate integrin
 

 
IIb
 

 
3, open the closed conformation of the 
 

 
IIb cytoplasmic
domain (Vinogradova et al., 2000). Interestingly, NMR
studies with recombinant “miniintegrins” in liposomes and
aqueous solution (Li et al., 2001; Ulmer et al., 2001) have not
confirmed interactions of the integrin 
 

 
IIb and 
 

 
3 cytoplasmic
domains. In contrast, other studies using smaller fragments of
the cytoplasmic domains suggested such interactions (Weljie
et al., 2002). These disparities may owe to subtle differences
in experimental conditions used. However, the interaction of
these cytoplasmic domains with each other may require some
third factor such as a membrane component or cytoplasmic
protein. Indeed, the interaction between these tails was
readily demonstrated in the presence of antibodies directed
against combinatorial epitopes formed by their interaction
(Ginsberg et al., 2001). However, it is clear that the changes
in the structure and/or interactions of the 
 

 
 and 
 

 
 tails is an
important determinant of integrin activation (O’Toole et
al., 1994; Hughes et al., 1996).
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How is the activation signal transmitted? 
 
How does reg-
ulatory information contained within the cytoplasmic do-
mains of integrins propagate through the transmembrane
domain to the ligand-binding site? Integrin transmembrane
domains are typically thought to begin after an extracellular
proline residue. The boundary between the transmembrane
domain and the cytoplasmic domain is less clear (Williams et
al., 1994). Most human integrin 
 

 
 and 
 

 
 subunits contain a
conserved, positively charged amino acid (Arg or Lys) posi-
tioned 
 

 
23 hydrophobic amino acid residues COOH-ter-
minal of the predicted start of the transmembrane domain.
This conserved K/R residue is generally (with the exception
of 
 

 
4 and 
 

 
8) immediately followed by a stretch of four to
six hydrophobic residues, resulting in the K/R residue being
flanked by hydrophobic regions. For this reason, it was pro-
posed previously to be a weak “stop transfer” signal, demar-
cating the beginning of integrin 
 

 
 and 
 

 
 cytoplasmic do-
mains (Williams et al., 1994). In an earlier review, we
proposed four alternative movements (involving the con-
served K/R residue) of the transmembrane domains relative
to each other to explain proposed allosteric rearrangements
in integrins (Williams et al., 1994). New evidence favors one
of those models, the “piston” model. Elegant glycosylation
mapping studies (Armulik et al., 1999) suggest that the hy-
drophobic region just COOH-terminal to the conserved K/R
is membrane-embedded in integrin subunits 
 

 
2, 
 

 
5, 
 

 
1,
and 
 

 
2. These same studies demonstrated that decreasing
the hydrophobicity of this region likely shortens the trans-
membrane domain by extending these residues out of the
membrane. This mobility of the transmembrane domain is
likely facilitated by the fact that the minimal length of hy-
drophobic residues required to span the plasma membrane is
 

 
20, and most of the integrin subunits contain a 27 residue
hydrophobic stretch (Williams et al., 1994) (inclusive of the
conserved K/R). Thus, the length or orientation of the inte-
grin transmembrane domains could vary depending on the
nature of this conserved hydrophobic region. Several “acti-
vating” mutations disrupt this hydrophobic region (O’Toole
et al., 1994; Hughes et al., 1996) and could result in a bias
toward the shorter transmembrane domain. Changes in the
length or orientation of the integrin transmembrane domain
could also occur during physiological integrin activation.
Binding of the cytoplasmic proteins such as talin to integrin
 

 
 cytoplasmic domains activates integrins (Calderwood et
al., 1999), and the binding site of the 
 

 
2 integrin regulatory
protein, cytohesin-1, is in this conserved hydrophobic region
of integrin 
 

 
2 (Nagel et al., 1998). Thus, the binding of pro-
teins to integrin cytoplasmic domains may change the border
of the integrin transmembrane and cytoplasmic domain in a
piston-like motion. Such changes could lead to the proposed
conformational rearrangements in the extracellular domains.
 
What is the intracellular activation signal? 
 
The central
role of integrin cytoplasmic domains in regulating activation
suggested that the regulated interaction of cytoplasmic pro-
teins with the integrin tails was a central control point in the
process (O’Toole et al., 1994). Two candidates for the prox-
imal regulators are cytohesin-1 and talin. The former is re-
ported to bind to the 
 

 
2 cytoplasmic domain and regulate
 

 
2 integrin–mediated adhesion in response to activation of
phosphatidylinositol 3-kinase (Nagel et al., 1998). Further-
 
more, cytohesin-1 is a guanine nucleotide exchanger for the
ARF GTPase, and both its exchange activity and capacity to
bind to the integrin cytoplasmic domain are required for its
effects on 
 

 
2 integrins. However, cytohesin-1 is 
 

 
2 integrin
specific. and integrin activation appears to be a general prop-
erty of these receptors. Thus, talin, which binds to most in-
tegrin 
 

 
 cytoplasmic domains (Calderwood et al., 1999),
may represent a more general activator.
Talin is an actin-binding protein that links integrins to
the actin cytoskeleton (Horwitz et al., 1986) and colocalizes
with clustered integrins. Furthermore, genetic and cell bio-
logical analyses show that talin is involved in integrin clus-
tering into focal adhesions (Priddle et al., 1998). Talin con-
sists of an NH
 
2
 
-terminal 
 

 
47-kD globular head domain
(talin-H) and an 
 

 
190-kD, COOH-terminal rod (talin-R)
domain (Rees et al., 1990). It is an elongated (60 nm), flexi-
ble protein that binds to the cytoplasmic domains of inte-
grins 
 

 
1A, 
 

 
1D (but not 
 

 
1B and 
 

 
1C), 
 

 
2, and 
 

 
3 (Liu et
al., 2000). The talin head domain contains a band four-
point-one, ezrin, radixin, moesin homology (FERM) do-
main and expression of talin fragments containing the head
domain or of the FERM domain alone (Calderwood et al.,
1999, 2002) activates integrins. The talin FERM domain is
similar to those present in ezrin, radixin, and moesin (ERM)
proteins (Pearson et al., 2000), which mediate the binding
of the ERM proteins to the cytoplasmic domains of certain
transmembrane receptors (Bretscher et al., 2000). In ERM
proteins, the membrane protein-binding site in the FERM
domains are masked in the intact molecule by interactions
with the COOH-terminal tail domain (Pearson et al.,
2000). The binding activity of the FERM domain can be
unmasked by phosphorylation or the interaction of ERM
proteins with polyphosphoinositides (Bretscher et al., 2000).
Similarly, talin’s integrin-binding site is masked in the intact
molecule and can be uncovered by proteolytic cleavage (Yan
et al., 2001) or binding to polyphosphoinositides (Martel et
al., 2001). Furthermore, talin can be phosphorylated; how-
ever, the effects of these phosphorylation events on integrin
binding have not been reported. Thus, talin is an integrin-
activating protein that can manifest regulated interactions
with integrin 
 

 
 cytoplasmic domains.
 
FERM and phosphotyrosine-binding domain–integrin
interactions; a structural paradigm for diversity in integrin
signaling. 
 
Based on the crystal structures of the FERM do-
mains from moesin, radixin, and band 4.1, the talin FERM
domain was predicted to contain three subdomains, F1, F2,
and F3. The isolated 96 amino acid F3 subdomain activates
integrins (Calderwood et al., 2002). The F3 domain was
predicted to be a sandwich of two orthogonal antiparallel 
 

 
sheets followed by an 
 

 
 helix resembling the phosphoty-
rosine-binding (PTB) domain. The interaction of integrin 
 

 
cytoplasmic domains with talin resembles the binding of a
PTB domain to a peptide ligand in several ways. PTB-bind-
ing sequences, including NPxY/F motifs, form 
 

 
 turns when
bound to a PTB domain (Forman-Kay and Pawson, 1999).
Talin-binding integrin 
 

 
 tails contain such NPxY/F motifs,
and the integrin 
 

 
3 NPxY motif has the propensity to form
a 
 

 
 turn (Ulmer et al., 2001). Mutations of the NPxY motif
abolish the transient 
 

 
 turn and block both talin binding
(Pfaff et al., 1998) and integrin activation (O’Toole et al.,
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1995). Additional PTB–ligand interactions are provided by
the amino acid sequence NH
 
2
 
-terminal to the 
 

 
 turn of the
recognition motif (Forman-Kay and Pawson, 1999). Consis-
tent with such an interaction, minimal talin-binding pep-
tides contain the conserved first NPxY motif of integrin 
 

 
1A
along with the preceding five amino acids (Horwitz et al.,
1986), providing additional similarities between the pep-
tide-binding properties of talin and authentic PTB domains.
Hence, the integrin 
 

 
 tail–talin interaction bears many of
the characteristics of PTB–ligand interactions, and the abil-
ity of the PTB-like talin F3 subdomain to activate integrins
may require a stable 
 

 
 turn at the conserved NPxY/F motif.
The NPxY-dependent integrin binding to the PTB-like
FERM subdomain of talin suggests general paradigms for
the control of cellular response to integrin-dependent cell
adhesion. There are a large number of FERM and PTB do-
main–containing proteins; thus, the remarkable conserva-
tion of the NPxY/F motif in integrin 
 

 
 subunits suggests the
possibility that other FERM and PTB domains might also
bind integrins. Furthermore, PTB domain binding to pep-
tide ligands may be favored or disfavored by phosphorylated
tyrosines in the context of NPxY motifs (Forman-Kay and
Pawson, 1999). In the case of integrin–PTB interactions,
the binding of talin F3 subdomain (Calderwood et al.,
2002) and ICAP-1
 
 
 
(Chang et al., 2002) to integrin 
 

 
 tails
is phosphorylation independent, whereas the binding of Shc
to the 
 

 
3 tail is favored by tyrosine phosphorylation (Cowan
et al., 2000). These several general principles of integrin–
cytoplasmic protein interaction are suggested. Specifically,
integrin 
 

 
 cytoplasmic domains may utilize their conserved
NPxY/F motifs to bind to cytoplasmic proteins that contain
PTB (or PTB-like) modules. Furthermore, by analogy with
the masking of the integrin-binding site in talin, posttransla-
tional modifications and interactions of the PTB domain–
containing proteins could regulate their binding to the inte-
grin tails. Conversely, tyrosine phosphorylation of the 
 

 
3
tail switches its PTB-binding preference from talin to Shc, a
shift likely to promote cell migration (Calderwood et al.,
2002). Thus, phosphorylation-regulated changes in PTB
domain binding specificity may represent molecular toggle
switches that designate biological responses to integrin-
dependent adhesion. Finally, as with talin and ICAP1-
 

 
, it
is likely that there will be integrin-specific PTB domain in-
teractions. The matrix of multiple integrin 
 

 
 tails and multi-
ple PTB domain proteins and the biochemical regulation of
their interactions provide a rich alphabet for encoding sig-
nals from integrins.
 
Activation and the integrin extracellular domain
 
Ligand-binding sites in integrins. 
 
At least three regions of
integrins have been implicated in ligand binding. Within all
 

 
 subunits, there exist seven repeated modules which were
predicted to fold into seven four-stranded 
 

 
 sheets arranged
in a torus around an axis of pseudosymmetry to form a 
 

 
propeller (Springer, 1997). The existence of this structure
has been confirmed in the crystal structure of 
 

 
v
 

 
3 (Xiong
et al., 2001), and its upper surface comprises a ligand-bind-
ing domain (Xiong et al., 2002). Second, at least eight inte-
grin 
 

 
 subunits contain a 
 

 
200 residue I (or A) domain that
participates in ligand binding. The I domains contain a
 
DXSXS motif that participates in coordinating bound cat-
ion (Lee et al., 1995). Two other coordination positions are
filled by oxygenated residues, a threonine and aspartic acid
near the DXSXS motif in the folded protein, but 
 

 
50 resi-
dues distant in the primary sequence. Thus, these residues
form the novel metal ion-dependent adhesion site (MIDAS)
(Lee et al., 1995). Several solved I domain structures indi-
cate that the overall structure is that of a dinucleotide-bind-
ing fold with a central parallel 
 

 
 sheet surrounded by 
 

 
 heli-
ces. The MIDAS motif lies at the COOH-terminal end of
the 
 

 
 sheet. Residues involved in ligand binding to the I do-
main cluster about the MIDAS face, with a glutamic acid
from the ligand completing the coordination sphere of the
metal ion (Emsley et al., 2000). Third, 
 

 
 subunits contain a
highly conserved DXSXS motif involved in ligand binding
that was predicted to be part of an I-like domain (Lee et al.,
1995). The existence of this I-like domain has been con-
firmed in the structure of integrin 
 

 
v
 

 
3 (Xiong et al.,
2001). Integrin activation is likely to involve alteration of
the secondary and tertiary structures of one or more of these
three modules. In addition, it seems likely that alterations of
the quaternary structure of the integrin leading to changes in
the physical relationships or accessibility of these modules
can regulate ligand-binding affinity (see below). 
 
Rearrangements in the tertiary structure of the I domain
and activation. 
 
The crystal structure of an integrin I do-
main–ligand complex demonstrates that conformational
changes are induced by ligand binding to the  subunit I
domain (Emsley et al., 2000). Such conformational changes
are likely to underlie affinity regulation. The structure of the
2 I domain in complex with a triple helical fragment of
collagen shows that ligand binding alters the conformation
of the I domain in a dramatic way; in particular, a subtle al-
teration in metal coordination at the MIDAS motif, which
allows the formation of a strong bond between the Mg2 ion
and a glutamic acid from the collagen, is linked to a 10 Å
shift of the COOH-terminal helix toward the lower surface
of the domain (Emsley et al., 2000). In the absence of the
conformational switch, collagen could still bind to the I do-
main, but it could not form a strong bond to the metal ion.
This immediately suggests that ligand-binding affinity is
regulated by the contacts between the lower surface of the
domain and the body of the integrin that restrain the con-
formational switch (see below). Structure-based mutagenesis
has confirmed, using “gain of function” studies, that these
conformational changes occur in the context of whole inte-
grin and underlie affinity regulation (Shimaoka et al., 2000).
The structural changes in the 2 collagen complex are essen-
tially identical to those seen earlier in two crystal forms of
the M I domain (Lee et al., 1995). Therefore, it seems very
likely that there are just two conformations for all  subunit
I domains (“open” and “closed”). For example, NMR data
are consistent with a similar conformational change in the
L-I domain (Legge et al., 2000). The next major challenge
is to understand the link between these tertiary changes in
the I domain and quaternary changes in the whole integrin.
Quaternary rearrangements in structure: lessons from
the structure of the v3 integrin extracellular domain.
Early electron microscopic and immunochemical studies
suggested that integrin activation was associated with large
836 The Journal of Cell Biology | Volume 158, Number 5, 2002
changes in the overall structure of the protein (Du et al.,
1993). Furthermore, activation appears to change the acces-
sibility of the ligand-binding pocket, suggesting that an im-
portant role for changing quaternary structure in the activa-
tion process (Beer et al., 1992). The recent determination
of the crystal structure of the complete extracellular portion
of integrin v3 (Xiong et al., 2001, 2002) provides a ma-
jor advance to the field and provides strong indications that
such quaternary rearrangements could underlie activation.
The v subunit lacks an -I domain, so the ligand-binding
head is comprised of the  subunit I–like domain (featuring
a MIDAS motif very similar to the  subunit MIDAS mo-
tif) sitting on top of the  subunit  propeller, very similar
to the arrangement seen in the G protein heterodimer
(Bohm et al., 1997). Now that we know the atomic details
of the association, however, we are in a much stronger posi-
tion to propose quaternary rearrangements that could lead
to activation.
The crystal structure shows that the  subunit propeller
and -I–like domain engage in an intimate embrace. With
respect to the long axis of the integrin (as deduced from EM
images), the propeller axis is tilted by nearly 90, with its axis
pointing into the side the -I domain, which inserts an argi-
nine side chain from a 310 helix into the cavity along the pro-
peller axis. The -MIDAS motif is exposed at the top of the
head, apparently available for binding ligands, whereas the
ligand-binding epitopes on the propeller are at least partly
obscured by the -I domain as predicted. Within the pub-
lished structures, we propose that the -I domain is in a
conformation that resembles the closed or inactive confor-
mation. First, the principal marker of the closed conforma-
tion is the position of the COOH-terminal helix (7) and
its connecting loop with respect to the central  sheet. In the
v3 crystal structure, this loop and helix are at the same
height as found in the closed conformation of the -I do-
main. Second, the arrangement of the MIDAS loops is
much more similar to that of the closed conformation. The
310 helix that inserts into the propeller axis is just a few resi-
dues upstream of the MIDAS loop 3 (Fig. 1); it is analogous
to the “switch II” region in G proteins, which is similarly
linked to changes in metal ion coordination, suggesting how
the packing of the integrin -I domain against the propeller
could regulate its conformation and affinity. Third, three
mutations that disrupt activation of integrin IIb3 (Baker
et al., 1997) map to residues on two strands (Fig. 1, B) adja-
cent to MIDAS loop 3. These strands could thus link con-
formational changes in the metal-binding loop to a large
shift of the COOH-terminal helix. Note that in the scheme
presented in Fig. 1, it is the -I domain that moves while the
7 helix remains fixed; however, the relative motion is the
same. We suggest that the effects of these mutations on acti-
vation provide strong circumstantial evidence that the inte-
grin -I domain undergoes comparable conformational
changes to those seen in -I domain.
In further support of this notion, the recent structure of
an RGD peptide ligand bound to crystals of V3 reveals
conformational changes within the -I domain that are in
the direction of those observed in the -I domain but appear
to be limited by the constraints of the quaternary organiza-
tion (Xiong et al., 2002). MIDAS loop 1 shifts by 2 Å to-
ward MIDAS loop 2, just as it does in -I, allowing a metal
ion to coordinate sidechains from both loops simulta-
neously. The top of the COOH-terminal helix appears to be
squeezed out by this motion, but the large motion of the
analogous helix observed in -I is prevented in -I by con-
tacts with the immunoglobulin-like hybrid domain (Xiong
et al., 2002). Similarly, MIDAS loop 3 is shifted little in the
liganded -I domain, and its movement is presumably frus-
trated by its link to the loop that locks into the propeller.
What kinds of quaternary motion are possible? The inter-
face between the -I and the  hybrid domains is principally
polar and could be disrupted with only small energetic con-
sequences. For example, a hinge motion somewhere around
E108-D109 (Fig. 1, pivot point) at the NH2 terminus of
Figure 1. Speculative model of the initial tertiary and quaternary 
changes during occupancy of activated integrins that lack an -I 
domain. Ligand binding to the MIDAS motif of the -I domain (M) 
triggers conformational changes in the three MIDAS loops (numbered 
1–3) that cause a shift of helix 1 and MIDAS loop 3 toward the 
F-7 loop (black arrows) and a loosening of the contacts between 
the -I domain and the propeller. These movements cause steric 
clashes that are relieved by a rotation of the -I domain around the 
indicated pivot point (red circle) at the hybrid–-I domain boundary, 
separating the -I from the propeller. Helix 7 remains in position, 
thus freeing itself from its contacts with MIDAS loop 3 and helix 1. 
That is, there is a net shift of helix 7 with respect to the -I domain 
as observed in the -I domain. Since occupancy activates integrins 
(Du et al., 1993), a reversal of the order of these events could account 
for integrin activation. In support of this idea, three mutations (B) 
shown previously to block activation (Baker et al., 1997) define a 
path between the movement of MIDAS loop 3 and helix 7; an 
activation epitope maps to the base of 1 (labeled H) at the -I–hybrid 
interface. Red highlighted loops on the propeller map the location 
of chimeras that switch ligand recognition specificities between 
integrin v and 5 subunits.
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-I–like domain could provide the necessary pull on the
COOH-terminal helix and lift the I-like domain clear of the
 propeller (Fig. 1). Thus, tertiary rearrangements within
the I-like domain of the  subunit could lead to activation as
suggested by the finding that (Mould et al., 2002) the
epitope for an activating antibody maps to the base of helix
1 of the -I domain (Fig. 1, H). Although the authors in-
terpreted this as evidence for a conformational change dis-
tinct from that of the -I domain, another interpretation is
that the antibody is recognizing the motion of the -I do-
main with respect to the -hybrid and propeller domain. A
piston-like quaternary shift of the  subunit could create
such a motion.
This model for activation proposed above extends the
analogy with the G proteins, where the I-like domain would
separate completely from the propeller during activation.
The structure would then resemble the EM images pre-
sented by Hantgan et al. (1999) of the activated state with
the head pieces separated. It could also allow for the 30 Å
separation of the distinct propeller and I domain ligand-
binding epitopes as determined by Mould et al. (1997) for
the binding of fibronectin to 51. We also note that it
may be necessary for the propeller to reorient such that its
ligand-binding surface becomes coplanar with that of the -I
domain; this would require a hinge motion in the  subunit,
either at the propeller-thigh interface or the “genu” as de-
fined by Arnaout and colleagues (Xiong et al., 2001).
Activation of integrins containing an -I domain. In
those integrins containing an  subunit I domain, it is
likely that the domain sits on top of the propeller, with its
COOH-terminal helix binding to and/or blocking the
-MIDAS motif. Those interactions with the -I domain
could lock the -I domain in the closed conformation or al-
ternatively, as proposed recently (Alonso et al., 2002), in an
open conformation. Thus, mutations to surface-exposed
residues on the COOH-terminal helix of the L-I domain
and the neighboring loop at the base of strand F lead to
activation of integrin L2, possibly by disrupting the in-
teractions between the - and -I domains (Lupher et al.,
2001). Similar activation occurs with mutation of the bur-
ied Ile235 to Ala, which disrupts the packing of the COOH-
terminal helix against the body of the -I domain (Xiong et
al., 2000). This intimate link between conformational
changes in the - and -I domains suggests that in some
cases the -I domain could regulate the -I domain rather
than serving as a primary ligand-binding site. This would
explain the apparent paradox that the -I domain is usually
the primary ligand-binding site, yet mutations in the -I
domain can often block ligand binding (Bajt et al., 1995).
It is also noteworthy that several mutations to the outside of
helix 7 and the COOH-terminal connector of -I do-
mains cause inactivation of the integrin (Lupher et al.,
2001). One interpretation of these data is that bonds be-
tween the -I and -I domains in the active state of the in-
tegrin stabilize the open state of the -I domain. Indeed,
Arnaout’s group (Alonso et al., 2002) has proposed that a
conserved Glu just COOH-terminal to the integrin I do-
main 7 helix is part of a ligand for the integrin -I do-
main. They suggest that the engagement of this internal
ligand leads to downward displacement of the 7 helix,
switching the  subunit I domain to its open conformation.
This proposed “ligand relay” mechanism would provide a
cogent explanation for bidirectional conformational rear-
rangements in the signaling reactions of integrins that pos-
ses -I domains.
Integrin bending and activation. The crystal structure of
v3 revealed a surprising quaternary structure. The
“stalks” of both subunits were severely bent bringing the
“head region,” including the propeller and thigh domain in
the  subunit, and the I domain and hybrid domain of the
 subunit into close proximity to the presumed membrane
interface (Xiong et al., 2001). This structure does not con-
form to consensus view of the integrin structure in mem-
branes or in solution as derived from rotary shadowed im-
ages (Parise and Phillips, 1985; Du et al., 1993) and
biophysical measurements (Hantgan et al., 1999). Although
some of these bends may reflect an underlying flexibility,
they are the sites of major crystal contacts within the crystal
lattice, suggesting that the bends are induced by crystalliza-
tion. Furthermore, some of the stalk domains are poorly or-
dered, which is suggestive of a strained conformation.
However, it is noteworthy that the COOH termini of the
two chains are found in close proximity, since prior muta-
tional studies have established that the separation of these
COOH termini leads to activation of integrin 51 (Tak-
agi et al., 2001). Blacklow, Springer, and colleagues have
shown that the epitopes for two activating antibodies map
to the outside of the  thigh domain, but are obscured by
the  hybrid domain in the crystal structure, leading them
to suggest that the bent conformation represents the inac-
tive integrin. They further propose that a “switch-blade”
opening of the integrin is associated with activation (Beg-
lova et al., 2002). Clearly, evidence from EM studies is re-
quired to support this model.
In summary, both the tertiary structure of the -I–like do-
main and its mode of association with the propeller (as de-
scribed above) and the interaction of the COOH termini sug-
gest that the V3 crystal structure is not in the high affinity
(active) state. Indeed, if the active or open state does resemble
the G protein, then it is unlikely that it could be crystallized
in the absence of a bivalent ligand that engaged both the -I
domain and propeller. However, the soluble V3 crystal-
lized by Arnaout and colleagues had been shown previously to
bind ligand in the presence of Mn and to therefore be ac-
tive in solution (Mehta et al., 1998). Clearly, a precise defini-
tion of the activation state of the solved V3 structure will
be essential in understanding the activation process.
Concluding remarks
Several mechanisms can modulate cell adhesion. Among
them is the regulation of integrin affinity for ligand. Affinity
regulation has been observed for many integrins and has im-
portant functional consequences in development, angiogen-
esis, hemostasis, wound repair, inflammation, and immu-
nity. Importantly, affinity changes can have their major
impact on integrin functions other than adhesion, such as
cell migration or assembly of a fibronectin matrix. Integrin
cytoplasmic domains control integrin activation. The mech-
anism by which structural information contained within
these cytoplasmic domains is propagated through integrin
838 The Journal of Cell Biology | Volume 158, Number 5, 2002
transmembrane domains to influence ligand binding contin-
ues to be an area of intense interest. Understanding the
mechanisms of integrin activation will provide insight into a
signal transduction event of broad biological significance.
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